“Abemaciclib in Real Clinical Practice of Adjuvant Therapy of HR+ HER2- High-Risk Breast Cancer: Experience of Centers in Moscow”. Voprosy onkologii 71, no. 3 (June 30, 2025): OF-2319. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/3-25-Abemaciclib-in-real-clinical-practice-of-adjuvant.